Outbreak of KPC-3 producing carbapenem- resistant Klebsiella pneumoniae in a US pediatric hospital

Journal of the Pediatric Infectious Diseases Society

Volumn 4, Issue 4, 2015, Pages 330-338

  Stillwell, Terri ^a   Green, Michael ^b   Barbadora, Karen ^b   Ferrelli, Juliet G ^c   Roberts, Terri L ^b   Weissman, Scott J ^d   Nowalk, Andrew ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c MERCY HOSPITAL OF PITTSBURGH   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

Carbapenemase; Infection control; Klebsiella pneumoniae; Nosocomial infection; Pediatric

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE; CARBAPENEMASE; CIPROFLOXACIN; KLEBSIELLA PNEUMONIAE CARBAPENEMASE 3; QUINOLONE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FIELD INVERSION GEL ELECTROPHORESIS; FOLLOW UP; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MEDICATION COMPLIANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CROSS INFECTION; DRUG EFFECTS; EPIDEMIC; HOSPITAL; KLEBSIELLA INFECTIONS; MULTILOCUS SEQUENCE TYPING; PRESCHOOL CHILD; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 85006218242     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu080     Document Type: Article

References (44)

1. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-61.
2. Wendt C, Schutt S, Dalpke AH, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29:563-70.
3. Pournaras S, Protonotariou E, Voulgari E, et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64:348-52.
4. Navon-Venezia S, Leavitt A, Schwaber MJ, et al. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 2009; 53:818-20.
5. Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S. Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel. Antimicrob Agents Chemother 2010; 54:3002-6.
6. Le J, Castanheira M, Burgess DS, McKee B, Iqbal R, Jones RN. Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California. J Clin Microbiol 2010; 48: 623-5.
7. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53:3365-70.
8. Goldfarb D, Harvey SB, Jessamine K, Jessamine P, Toye B, Desjardins M. Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission. J Clin Microbiol, 2009; 47:1920-2.
9. Fontana C, Favaro M, Sarmati L, et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010; 3:40.
10. Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 2009; 63:427-37.
11. Queenan AM, Bush K. Carbapenemases: the versatile betalactamases. Clin Microbiol Rev 2007; 20:440-58, table of contents.
12. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010; 65:1119-25.
13. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010; 31:341-7.
14. Gregory CJ, Llata E, Stine N, et al. Outbreak of carbapenemresistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010; 31:476-84.
15. Logan LK. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Clin Infect Dis 2012; 55:852-9.
16. Green M, Barbadora K, Michaels M. Recovery of vancomycinresistant gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 1991; 29:2503-6.
17. Green M, Barbadora K. Recovery of ceftazidime-resistant Klebsiella pneumoniae from pediatric liver and intestinal transplant recipients. Pediatr Transplant 1998; 2:224-30.
18. Horan TC, Andrus M, Dudeck MA, CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
19. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae-EUCAST and CLSI breakpoints. Clin Microbiol Infect, 2008; 14(Suppl 1):169-74.
20. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrob Agents Chemother 2010; 54:2687-91.
21. Jacoby G, Bush K. β-Lactamase Classification and Amino Acid Sequences for TEM, SHV and OXA Extended-Spectrum and Inhibitor Resistant Enzymes. September 30, 2010. Available from: http://www.lahey.org/Studies/.
22. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
23. Brisse S, Fevre C, Passet V, et al. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS ONE 2009; 4: e4982.
24. Bryant KA, Van Schooneveld TC, Thapa I, et al. KPC-4 Is encoded within a truncated Tn4401 in an IncL/M plasmid, pNE1280, isolated from Enterobacter cloacae and Serratia marcescens. Antimicrob Agents Chemother 2013; 57:37-41.
25. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob Agents Chemother 2008; 52:1257-63.
26. Aschbacher R, Giani T, Corda D, et al. Carbapenemaseproducing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting. Diagn Microbiol Infect Dis 2013; 77:354-6.
27. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34:1-14.
28. Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62:165-70.
29. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008; 29:1099-106.
30. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52:1028-33.
31. Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009; 30:972-6.
32. Chang HJ, Hsu PC, Yang CC, et al. Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study. J Microbiol Immunol Infect 2011; 44:125-30.
33. Neuner EA, Yeh JY, Hall GS, et al. Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 2011; 69:357-62.
34. Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother 2012; 67:2860-4.
35. Lo A, Verrall R, Williams J, Stratton C, Della-Latta P, Tang YW. Carbapenem resistance via the blaKPC-2 gene in Enterobacter cloacae blood culture isolate. South Med J 2010; 103:453-4.
36. Liu Y, Li XY, Wan LG, Jiang WY, Li FQ, Yang JH. Molecular characterization of the bla(KPC-2) gene in clinical isolates of carbapenem-resistant Klebsiella pneumoniae from the pediatric wards of a Chinese hospital. Can J Microbiol 2012; 58: 1167-73.
37. Little ML, Qin X, Zerr DM, Weissman SJ. Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae. Int J Antimicrob Agents 2012; 39:52-7.
38. Performance standards for antimicrobial susceptibility testing; update, 2010, CLSI: CLSI document M100-S20.
39. Rice LB, Carias LL, Hutton RA, Rudin SD, Endimiani A, Bonomo RA. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008; 52:3427-9.
40. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother 2009; 64(Suppl 1):i29-36.
41. Chia JH, Su LH, Lee MH, et al. Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure. Microb Drug Resist 2010; 16:317-25.
42. Gatt M, Reddy BS, MacFie J. Review article: bacterial translocation in the critically ill-evidence and methods of prevention. Aliment Pharmacol Ther 2007; 25:741-57.
43. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64(Suppl 1): i3-10.
44. D'Alincourt Carvalho-Assef AP, Leao RS, da Silva RV, et al. Escherichia coli producing KPC-2 carbapenemase: first report in Brazil. Diagn Microbiol Infect Dis 2010; 68:337-8.